PDF(1473 KB)
Value of serum S100B protein and neuron-specific enolase levels in predicting the severity of hand, foot and mouth disease
LI Jing, LIU Rui-Hai, SHAN Ruo-Bing
Chinese Journal of Contemporary Pediatrics ›› 2017, Vol. 19 ›› Issue (2) : 182-187.
PDF(1473 KB)
PDF(1473 KB)
Value of serum S100B protein and neuron-specific enolase levels in predicting the severity of hand, foot and mouth disease
Objective To study the value of serum S100B protein and neuron-specific enolase (NSE) levels in predicting the severity of hand, foot and mouth disease (HFMD). Methods Ninety children with HFMD were classified into three groups: common type, severe type, and critical type (n=30 each). Thirty healthy children were randomly selected as the control group. ELISA was used to measure serum levels of S100B protein and NSE before and at 7 days after treatment. The receiver operating characteristic (ROC) curve was used to evaluate the prediction efficiency of S100B protein and NSE for the severity of HFMD. Results The critical type group had significant increases in the serum levels of S100B protein and NSE compared with the other three groups (P < 0.01). The severe type group had significant increases in serum levels of S100B protein and NSE compared with the common type and control groups (P < 0.01). The critical type and severe type groups had significant reductions in serum levels of S100B protein and NSE after treatment (P < 0.05). Serum S100B protein had the highest Youden value of 0.611 at the cut-off value of 0.445 μg/L, with a sensitivity of 61% and a specificity of 100%, in the prediction of serious HFMD (including severe type and critical type HFMD). Serum NSE had the highest Youden value of 0.533 at the cut-off value of 5.905 μg/L, with a sensitivity of 80% and a specificity of 73%, in the prediction of serious HFMD. Combined measurements of these two parameters had a sensitivity of 86% and a specificity of 73% and had the highest predictive value for serious HFMD. Conclusions The serum levels of S100B protein and NSE help to predict the severity and treatment outcomes of HFMD. Combined measurements of these two parameters has a higher predictive value for serious HFMD.
Hand, foot and mouth disease / S100B protein / Neuron-specific enolase / Child
[1] 施学文,闫钢风,邵雷.手足口病合并脑膜炎的早期预测因素分析[J].临床儿科杂志,2012,30(11):1016-1019.
[2] Chong CY,Chan KP,Shah VA,et a1.Hand,foot and mouth disease in Singapore:a comparison of fatal and nonfatal cases[J].Acta Pediatr,2003,92(10):1163-1169.
[3] Chen KT,Chang HL,Wang ST,et al.Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan,1998-2005[J].Pediatrics,2007,120(2):e244-e252.
[4] 严秀峰,葛艳玲,谢新宝,等.上海地区重症手足口病住院患儿临床分析[J].中华儿科杂志,2012,50(4):271-275.
[5] 杜潘艳,赵丽梅,王晓波.肠道病毒71型感染手足口病患儿脑脊液干扰素-γ、白介素10、S100B和乳酸水平检测及意义[J].中国免疫学杂志,2015,31(7):952-954.
[6] 李新成,王宏伟,申保生.手足口病合并脑炎患儿脑脊液和血清细胞因子的测定及意义[J].中国现代药物应用,2014,8(8):5-7.
[7] 中华人民共和国卫生部.手足口病诊疗指南(2010年版)[J].国际呼吸杂志,2010,30(24):1473-1475.
[8] Wu JM,Wang JN,Tsai YC,et al.Cardiopulmonary manifestations of fulminant enterovirus 71 infection[J].Pediatrics,2002,109(2):E26.
[9] 乐高钟,吴小秧,文如泉,等.血清S-100B、神经烯醇化酶在重型手足口病患儿颅脑损伤中的检测意义[J].实用医学杂志,2014,30(3):412-415.
[10] Donato R,Cannon BR,Sorci G,et al.Functions of S100 proteins[J].Curr Mol Med,2013,13(1):24-57.
[11] Michetti F,Cazzlo D.S100B protein in biological fluids:a tool for perinatal medicine[J].Clin Chem,2002,48(12):2097-2104.
[12] 李季林,盛罗平.S100B蛋白与颅脑损伤研究的新进展[J].创伤外科杂志,2011,13(2):177-179.
[13] Staffa K,Ondruschka B,Franke H,et al.Cerebellar gene expression following human traumatic brain injury[J].J Neurotrauma,2012,29(17):2716-2721.
[14] Lo TY,Jones PA,Minns RA.Pediatric brain trauma outcome prediction using paired serum levels of inflammatory mediators and brain-specific proteins[J].J Neurotrauma,2009,26(9):1479-1487.
[15] 王鹏高,施新革,赵文增.S100蛋白与体外循环脑损伤[J].新乡医学院学报,2006,23(4):426-428.
[16] Hayakata T,Shiozaki T,Tasaki O,et al.Changes in CSF S-100B and cytokine concentrations in early-phase severe traumatic brain injury[J].Shock,2004,22(2):102-107.
[17] 高鹏.精神分裂症患者血清S100B蛋白检测的临床意义[J].中国基层医药,2010,17(16):2238.
[18] 汤卫红,江雪娟,王惠庭,等.病毒性脑炎患儿NSE、S100B蛋白和神经肽Y水平变化的研究[J].中国医师杂志,2010,12(4):477-479.
[19] 云永利,张晖,王宝军,等.癫痫患者血清S100B的变化及其与影响因素的相关性[J].中华神经科杂志,2010,43(4):282-283.
[20] 李邦林.急性缺血性脑卒中患者血清S100B蛋白变化的临床意义[J].中国实用神经疾病杂志,2010,12(13):31-32.
[21] Unden J,Christensson B,Bellner J,et al.Serum S100B levels in patients with cerebral and extracerebral infectious disease[J].Scand J Infect Dis,2004,36(1):10-13.
[22] 孙宝迪,邵旦兵,刘红梅,等.血清S100B蛋白联合降钙素原在初筛中枢神经系统感染中的应用价值[J].临床急诊杂志,2014,15(7):402-407.
[23] 张利亚,李岩,金美芳.新蝶呤和S100b在诊断儿童中枢神经系统感染中的价值[J].中国当代儿科杂志,2014,16(4):380-383.
[24] Lamers KJ,Vos P,Verbeek MM,et al.Protein S100B,neuronspecific enolase (NSE),myelin basic protein (MBP) and glial fibrilliy acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients[J].Brain Res Bull,2003,61(3):261-264.
[25] 丰炳峰,朱孔荣.手足口病合并病毒性脑炎患儿血清铁蛋白及神经元特异性烯醇化酶水平的变化及意义[J].中国当代儿科杂志,2012,14(7):515-517.
